Content
07/19/2024
South San Francisco, CA USA
Neurona Therapeutics
completed $35 million Series A Round funding. Investors include
LongRiver Investments (lead), Lilly Asia Ventures, BioTrack Capital.
About
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Startup
Neurona Therapeutics
https://www.neuronatherapeutics.com
Claim Profile
Location:
South San Francisco, CA USA
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
